Trials / Completed
CompletedNCT03876210
Study to Compare the Safety and Pharmacokinetics of PK101 With Coadministration of the Two Separate Drugs
A Randomized, Open-label, Single Dose, 2x2 Crossover Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics After Administration of Fixed-dose Combination or Loose Combination of PK101 in Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 47 (actual)
- Sponsor
- PMG Pharm Co., Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the safety and pharmacokinetics of PK101(fixed-dose combination of PK101-001 and PK101-002) with coadministration of the two separate drugs in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | PK101 | PK101-001 + PK101-002 (combination) |
| DRUG | PK101-001, PK101-002 | coadministration |
Timeline
- Start date
- 2019-07-12
- Primary completion
- 2019-07-22
- Completion
- 2019-08-05
- First posted
- 2019-03-15
- Last updated
- 2019-09-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03876210. Inclusion in this directory is not an endorsement.